Rotapharm Limited in London, N3 2JU

Description

Data updated on: 01-11-2023

Rotapharm Limited has existed in the business for nineteen years. Started with Registered No. 05596694 in the year 2005, it have office at Ground Floor, Gadd House, London N3 2JU. The enterprise's SIC code is 46460: Wholesale of pharmaceutical goods. Rotapharm Ltd reported its account information for the period up to 2022-12-31. The company's most recent annual confirmation statement was released on 2023-06-21.

Right now, this firm is overseen by 1 director: Serkan U., who was assigned this position on 2019-11-01. Since 2015 Tony D., had been managing the following firm till the resignation in November 2019. In addition another director, including Raushan T. gave up the position on 2015-01-01.

Rafael T. is the individual who controls this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-12-31	2012-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Currency
Net Worth	206 429	293 742

Balance Sheet
Cash Bank On Hand			61 433	58 364	90 648	32 150	36 716	82 673
Current Assets	531 694	822 124	1 216 781	1 127 528	1 991 406	683 477	292 967	1 108 068
Debtors	116 498	421 937	986 703	1 069 164	1 900 758	651 327	256 251	1 025 395
Net Assets Liabilities			651 824	309 170	178 467	209 967
Other Debtors			18 215			163 814	256 251	1 025 395
Total Inventories			168 645
Cash Bank In Hand	415 196	400 187
Intangible Fixed Assets	27 087	23 492
Net Assets Liabilities Including Pension Asset Liability	206 429	293 742
Tangible Fixed Assets	3 778	2 157

Capital & Reserves
Called Up Share Capital	2	2
Profit Loss Account Reserve	206 427	293 740
Shareholder Funds	206 429	293 742

Other Financial Data
Audit Fees Expenses			3 000	3 000	3 000	3 000
Accrued Liabilities Deferred Income			4 100	4 100	4 100	4 200
Accumulated Amortisation Impairment Intangible Assets			30 433	34 028	35 950	35 950
Accumulated Depreciation Impairment Property Plant Equipment			40 429	40 429	40 429	40 429
Administration Support Average Number Employees			6	1
Administrative Expenses			141 871	122 365	117 571	32 670
Amortisation Expense Intangible Assets			3 595	3 595	1 922
Amounts Owed By Group Undertakings Participating Interests				223 108
Applicable Tax Rate				19	19	19
Average Number Employees During Period				1	1	1	1	1
Corporation Tax Payable			10 317	21 224	37 904	6 931	7 533	7 138
Cost Sales			1 707 900	6 890 622	8 538 325	3 719 192
Creditors			570 474	820 280	1 812 939	473 511	50 889	1 077 642
Current Tax For Period			10 317	33 336	37 904	7 389
Deferred Tax Expense Credit Relating To Origination Reversal Timing Differences			-1 293
Deferred Tax Liabilities
Depreciation Expense Property Plant Equipment			6 464
Distribution Costs						7 151
Dividends Paid				481 177	290 371
Finished Goods Goods For Resale			168 645
Future Minimum Lease Payments Under Non-cancellable Operating Leases			36 431	36 431
Gross Profit Loss			145 852	293 613	308 969	78 679
Increase Decrease In Deferred Tax Liability From Amount Recognised In Profit Or Loss			-1 293
Increase From Amortisation Charge For Year Intangible Assets				3 595	1 922
Intangible Assets			5 517	1 922
Intangible Assets Gross Cost			35 950	35 950	35 950	35 950
Net Current Assets Liabilities	175 564	268 093	646 307	307 248	178 467	209 967	242 078	30 426
Nominal Value Allotted Share Capital			2	2	2	2
Number Shares Issued Fully Paid				2	2	2
Operating Profit Loss			51 369	171 848	197 427	38 858
Other Creditors				3 800		4 199	7 200	5 400
Other Interest Receivable Similar Income Finance Income			32	11	145	31
Other Operating Income Format1			47 388	600	6 029
Par Value Share				1	1	1
Prepayments Accrued Income			17 880	15 427	1 199	1 199
Profit Loss			42 377	138 523	159 668	31 500
Profit Loss On Ordinary Activities Before Tax			51 401	171 859	197 572	38 889
Property Plant Equipment Gross Cost			40 429	40 429	40 429	40 429
Revenue From Sale Goods			1 853 752	7 184 235	8 847 294	3 797 871
Tax Expense Credit Applicable Tax Rate				32 653	37 539	7 389
Tax Increase Decrease From Effect Expenses Not Deductible For Tax Purposes Other Than Goodwill Amortisation Impairment				683	365
Tax Tax Credit On Profit Or Loss On Ordinary Activities			9 024	33 336	37 904	7 389
Total Current Tax Expense Credit				33 336	37 904	7 389
Trade Creditors Trade Payables			556 057	791 156	1 770 935	462 380	36 156	1 065 104
Trade Debtors Trade Receivables			922 522	335 304	1 699 276	487 512
Turnover Revenue			1 853 752	7 184 235	8 847 294	3 797 871
Wages Salaries			19 113	15 000	9 000	11 500
Creditors Due Within One Year	356 130	554 031
Fixed Assets	30 865	25 649
Intangible Fixed Assets Aggregate Amortisation Impairment	8 863	12 458
Intangible Fixed Assets Amortisation Charged In Period		3 595
Intangible Fixed Assets Cost Or Valuation	35 950	35 950
Tangible Fixed Assets Cost Or Valuation	8 105	8 105
Tangible Fixed Assets Depreciation	4 327	5 948
Tangible Fixed Assets Depreciation Charged In Period		1 621
Total Assets Less Current Liabilities	206 429	293 742

Company staff

Serkan U.

Role: Secretary

Appointed: 01 November 2019

Latest update: 12 March 2024

Serkan U.

Role: Director

Appointed: 01 November 2019

Latest update: 12 March 2024

Tony D.

Role: Secretary

Appointed: 01 January 2015

Resigned: 01 November 2019

Latest update: 12 March 2024

Tony D.

Role: Director

Appointed: 01 January 2015

Resigned: 01 November 2019

Latest update: 12 March 2024

Zafer K.

Role: Secretary

Appointed: 05 April 2011

Resigned: 01 January 2015

Latest update: 12 March 2024

Raushan T.

Role: Director

Appointed: 30 September 2010

Resigned: 01 January 2015

Latest update: 12 March 2024

Paul W.

Role: Secretary

Appointed: 01 September 2009

Resigned: 05 April 2011

Latest update: 12 March 2024

Tony D.

Role: Director

Appointed: 01 September 2009

Resigned: 30 September 2010

Latest update: 12 March 2024

Zafer K.

Role: Secretary

Appointed: 27 May 2009

Resigned: 01 September 2009

Latest update: 12 March 2024

Zafer K.

Role: Director

Appointed: 27 May 2009

Resigned: 01 September 2009

Latest update: 12 March 2024

Stanley W.

Role: Secretary

Appointed: 19 October 2005

Resigned: 27 May 2009

Latest update: 12 March 2024

Kellee F.

Role: Director

Appointed: 19 October 2005

Resigned: 27 May 2009

Latest update: 12 March 2024

People with significant control

Rafael T.

Notified on 5 May 2022

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Raushan T.

Notified on 15 October 2016

Ceased on 5 May 2022

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	05 July 2024
Confirmation statement last made up date	21 June 2023

Annual Accounts 22 April 2013
Start Date For Period Covered By Report	2012-01-01
End Date For Period Covered By Report	2012-12-31
Date Approval Accounts	22 April 2013
Annual Accounts
Start Date For Period Covered By Report	2018-01-01
End Date For Period Covered By Report	31 December 2018
Annual Accounts
Start Date For Period Covered By Report	2019-01-01
End Date For Period Covered By Report	31 December 2019
Annual Accounts
Start Date For Period Covered By Report	2020-01-01
End Date For Period Covered By Report	31 December 2020
Annual Accounts
Start Date For Period Covered By Report	2021-01-01
End Date For Period Covered By Report	2021-12-31
Annual Accounts
Start Date For Period Covered By Report	2022-01-01
End Date For Period Covered By Report	2022-12-31

Rotapharm Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Serkan U.

Serkan U.

Tony D.

Tony D.

Zafer K.

Raushan T.

Paul W.

Tony D.

Zafer K.

Zafer K.

Stanley W.

Kellee F.

People with significant control

Rafael T.

Raushan T.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies